These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1361324)

  • 1. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.
    Yue TL; McKenna PJ; Lysko PG; Ruffolo RR; Feuerstein GZ
    Atherosclerosis; 1992 Dec; 97(2-3):209-16. PubMed ID: 1361324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.
    Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1442-9. PubMed ID: 7791119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation.
    Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1995 Dec; 294(2-3):585-91. PubMed ID: 8750722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
    Yue TL; Mckenna PJ; Lysko PG; Gu JL; Lysko KA; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1994 Jan; 251(2-3):237-43. PubMed ID: 8149979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
    J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
    Yue TL; Mckenna PJ; Gu JL; Cheng HY; Ruffolo RR; Feuerstein GZ
    Hypertension; 1993 Dec; 22(6):922-8. PubMed ID: 7902335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
    Yue TL; McKenna PJ; Ruffolo RR; Feuerstein G
    Eur J Pharmacol; 1992 Apr; 214(2-3):277-80. PubMed ID: 1355437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension.
    Maggi E; Marchesi E; Covini D; Negro C; Perani G; Bellomo G
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):532-8. PubMed ID: 8847870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
    Yue TL; McKenna PJ; Gu JL; Cheng HY; Ruffolo RE; Feuerstein GZ
    Cardiovasc Res; 1994 Mar; 28(3):400-6. PubMed ID: 7909721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ; Ruffolo RR
    Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation.
    Noguchi N; Nishino K; Niki E
    Biochem Pharmacol; 2000 May; 59(9):1069-76. PubMed ID: 10704936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
    Hanna AN; Feller DR; Witiak DT; Newman HA
    Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids.
    Rattan AK; Arad Y
    Atherosclerosis; 1998 Feb; 136(2):305-14. PubMed ID: 9543102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.
    Oettl K; Greilberger J; Zangger K; Haslinger E; Reibnegger G; Jürgens G
    Biochem Pharmacol; 2001 Jul; 62(2):241-8. PubMed ID: 11389884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells.
    Lesnik P; Dachet C; Petit L; Moreau M; Griglio S; Brudi P; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):979-88. PubMed ID: 9157964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.
    Lysko PG; Lysko KA; Yue TL; Webb CL; Gu JL; Feuerstein G
    Stroke; 1992 Nov; 23(11):1630-5; discussion 1635-6. PubMed ID: 1440712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of EDTA on the oxidation of low density lipoprotein.
    Lamb DJ; Leake DS
    Atherosclerosis; 1992 May; 94(1):35-42. PubMed ID: 1632857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of carvedilol.
    Ruffolo RR; Gellai M; Hieble JP; Willette RN; Nichols AJ
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S82-8. PubMed ID: 1974511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.
    Fahlbusch SA; Tsikas D; Mehls C; Gutzki FM; Böger RH; Frölich JC; Stichtenoth DO
    Eur J Clin Pharmacol; 2004 Apr; 60(2):83-8. PubMed ID: 15004731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.